IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Changes in Blood Flow in MCA of Fetuses to Mothers Having Clinical Chorioamnionitis
The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2006 by Hadassah Medical Organization.
Recruitment status was: Recruiting
Recruitment status was: Recruiting
Sponsor:
Hadassah Medical Organization
Information provided by:
Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT00299637
First received: March 5, 2006
Last updated: November 29, 2006
Last verified: March 2006
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This study will try to determine whether fetuses to mothers having clinical chorioamnionitis have changes in blood flow in middle cerebral artery.
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Observational Model: Natural History Time Perspective: Cross-Sectional Time Perspective: Prospective |
| Official Title: | Changes in Blood Flow in MCA of Fetuses to Mothers Having Clinical Chorioamnionitis During Labor Comparing to Fetuses to Healthy Mothers. |
Resource links provided by NLM:
Further study details as provided by Hadassah Medical Organization:
| Estimated Enrollment: | 34 |
| Study Start Date: | October 2006 |
| Estimated Study Completion Date: | December 2007 |
This study will try to determine whether fetuses to mothers having clinical chorioamnionitis have changes in blood flow in middle cerebral artery.
MCA flow parameters will be evaluated during labor of women with and wthout chorioamnionitis
Eligibility| Ages Eligible for Study: | 20 Years to 45 Years (Adult) |
| Sexes Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- women giving birth week 37-42
- healthy
- one fetus
Exclusion Criteria:
- more than one fetus
- IUGR
- illness or damage to fetus
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00299637
Please refer to this study by its ClinicalTrials.gov identifier: NCT00299637
Contacts
| Contact: david mankuta, MD | mankuta@yahoo.com |
Locations
| Israel | |
| Haddasah Medical Organization | Recruiting |
| Jerusalem, Israel, 12000 | |
| Contact: David Mankuta | |
| Principal Investigator: David Mankuta | |
Sponsors and Collaborators
Hadassah Medical Organization
Investigators
| Study Chair: | David Mankuta, MD | Hadassah Medical Organization |
More Information
| ClinicalTrials.gov Identifier: | NCT00299637 History of Changes |
| Other Study ID Numbers: |
MCA chorioamnionitis HMO-CTIL |
| Study First Received: | March 5, 2006 |
| Last Updated: | November 29, 2006 |
Additional relevant MeSH terms:
|
Chorioamnionitis Fetal Diseases Pregnancy Complications |
Fetal Membranes, Premature Rupture Obstetric Labor Complications Placenta Diseases |
ClinicalTrials.gov processed this record on June 23, 2017